Last edition
News about "Peripheral thyrotoxicosis treatment"
US FDA Approves First Treatment for MCT8 Deficiency
The US FDA has approved the first treatment for MCT8 deficiency, designed to bypass the defective transporter and lower elevated blood thyroid hormone levels.
Peripheral Thyrotoxicosis Treatment | 30/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members